Discover how Global MedTech leaders Turn Market Ambiguity Into Confident Growth Decisions.

Challenge

A global MDx leader wanted to accelerate growth in APAC and LATAM but lacked credible, comparable market data to validate investments. Mature markets were stagnating, emerging markets were opaque, and regional teams could not confidently prioritize resources or defend budgets.

How we helped

Clearstate deployed the Market Size and Share Tracker, giving the client a granular, comparable data across a wide range of MDx product categories, across 16 APAC and 10 LATAM markets.

To strengthen decision-making, we layered in country-specific market intelligence, including macroeconomic signals, disease burden trends, regulatory and reimbursement developments, and key industry dynamics. Together, these insights enabled the client to shape more effective, locally attuned commercial strategies.

Results

Clearstate’s Market Size & Share Tracker gave the client full visibility into the true addressable opportunity across their key product categories in 16 APAC and 10 LATAM markets. With a clear view of market value pools, the client were able to prioritize investments, optimize resources, and focus on the segments with the highest return potential. The country-specific insights also equipped teams with evidence-backed narratives for internal presentations and business case alignment.

The tracker is now renewed annually and serves as a core tool for safeguarding growth in emerging markets.